SUMMARY The development of a purpura-fulminans-like disorder which is a human equivalent of a local Shwartzman reaction in a woman with active chronic hepatitis is described. The cyclical appearance of blue-black, well circumscribed, haemorrhagic, acutely painful lesions in the buttocks, over the lateral aspects of the thighs, and on the arms suggested the diagnosis. Evidence of increased intravascular coagulation was obtained although interpretation of clotting factor deficiencies in the presence of parenchymal liver disease was difficult. Treatment with heparin arrested the disorder on three separate occasions. The reasons for the development of the syndrome are not clear and even more surprising was the occurrence of such a disorder in the presence of increased fibrinolysis. While disseminated intravascular coagulation has been described in association with liver disease, the development of features of purpura fulminans in such patients does not appear to have been noted.
The Shwartzman reaction is an experimental animal entity which may be local or general. The local Shwartzman reaction is confined to a prepared tissue site, usually the skin. Local injection of a 'preparing' agent (classically Gram-negative endotoxin) followed 24 hours later by intravenous injection of a 'provoking' agent leads to intravascular coagulation with haemorrhagic necrosis of the prepared site. In the generalized Shwartzman reaction two intravenous injections of Gramnegative endotoxin 24 hours apart lead to intravascular coagulation with resultant fibrin thrombi and renal cortical necrosis (Hjort and Rapaport, 1965) . Human disorders resembling Shwartzman reactions in animals have been termed 'Shwartzman equivalent' states (Colman and Rodriguez-Erdman, 1970 
PROGRESS REPORT
Five days after admission the patient's condition became critical with widespread painful haematomas forming over the arms, legs, and trunk (see Figure) . She was given a platelet infusion (concentrate prepared from four donors); hydrocortisone 100 mg intravenously and started on prednisolone 60 mg daily. Her condition worsened and she developed hepatic precoma requiring treatment with protein restriction and neomycin. Results of coagulation studies carried out during the sixth and seventh days are summarized in theTable. Therewas also some evidence for fibrinolysis as shown by the plasminogen 
Local 'Shwartzman equivalent' reaction in active chronic hepatitis
The term describes any condition in which depletion of clotting factors I, II. V, VIII, and platelets occurs, with or without compensatory fibrinolysis and regardless of the mechanism by which the clotting system has been activated (Colman and RodriguezErdman, 1970) . Likewise a considerable number of human 'Shwartzman equivalent' states have been described (Ackerman, 1942; McKay, Merrill, Weiner, Hertig, and Reid, 1953; McKay, Jewett, and Reid, 1959; Hardaway, Husni, Geever, Hjort and Rapaport, 1965; Moncrieff and Glasgow, 1970) . Disease states resembling both a general and local Shwartzman reaction may occur and in the human, unlike the rabbit, distinction is often difficult. The present patient had many features characteristic of purpura fulminans, a human equivalent of a local Shwartzman reaction. Purpura fulminans usually occurs in children one to four weeks after an infectious preparatory disease (Hjort, Rapaport, andJorgensen, 1964; Antley and McMillan, 1967 ) associated with leucocytosis, thromhocytopenia, and evidence of intravascular coagulation.
Several days elapsed before the diagnosis of disseminated intravascular coagulation was made in this patient. Initially, it was thought that the bleeding tendency was a manifestation of thrombocytopenia anld parenchymal liver disease. The bone marrow result raised the possibility of idiopathic thrombocytopenic purpura but hypersplenism and systemic lupus erythematosus were also considered. Treatment with platelet concentrates and corticosteroids on the fifth day after admission failed to produce a favourable response and, indeed, her condition worsened. The presence ofa circulating anticoagulant of the heparin type was suspected but disproved.
The skin lesions were typical of purpura fulminans. The lesions were dark blue, well circumscribed, and appeared in a cyclical fashion. They were extremely painful and in some instances underwent necrosis with subsequent tissue damage. Clotting factors were in keeping with a state of intravascular consumption coagulopathy although interpretation was difficult due to underlying liver disease which of itself may lower vitamin K-dependent factors, namely, factors II, VII, IX, and X in addition to factor V and platelets.
During her 'normal' periods, between episodes of intravascular coagulation, she had intermittently low levels of factor II, V, and fibrinogen but normal levels of factor VIII (Table I ). Her platelet count had been low for five years. During her attacks, factors IL and V fell further as did fibrinogen and platelets, whilst factor VIII fell but remained within normal limits (Table I) . Improvement in the levels of all these factors followed recovery from each episode of intravascular coagulation. Recovery 3 seemed to occur only after the introduction of heparin therapy although the adnministration of antibiotics concomitantly may have played some part. Corticosteroid therapy alone appeared to have no beneficial effect and indeed the patient's condition worsened following the introduction of this treatment. It is of interest that on the third occasion we treated this patient she had an actual rise of factor VIII to 150% before treatment, the level reverting to normal after heparin therapy. A similar finding has been reported by Zetterqvist and Von Franken (1963) .
The occurrence of disseminated intravascular coagulation in patients with liver disease has been reported by several authors (Zetterqvist and Von Franken, 1963; Johansson, 1964; Rake, Flute, Pannell, and Williams, 1970) . Manifestations of a local Shwartzman reaction do not appear to have occurred in these patients. The presence of consumption coagulopathy alone, however, is insufficient for the development of the Shwartzman reaction, other modifying factors, particularly defective fibrinolysis, being necessary (Colman and Rodriguez-Erdman, 1970 ). The pathogenesis underlying the acute illness in the present patient is unknown as is the role of her liver disease. Increased, rather than decreased, fibrinolytic activity has been described in many forms of liver disease (Von Kaulla, 1963) though it is poorly correlated with clinical bleeding disorders in such patients. The present patient also had some evidence of increased fibrinolysis. Although a mild infection did precede one episode, there was no other evidence to suggest endotoxic shock nor was she gravid during any of her attacks.
The clinical features, course, and response to heparin were fully consistent with a diagnosis of purpura fulminans, a human equivalent of a local Shwartzman reaction. Heparin therapy prevents the experimental Shwartzman reaction (Good and Thomas, 1953) and there is good evidence of its value in human equivalent states (Hjort and Rapaport, 1965) . Corticosteroids potentiate the Shwartzman reaction and, while they may be necessary to combat shock, should probably only be administered in addition to heparin where this syndrome is suspected
The difficulty of diagnosis in patients with cirrhosis who develop a bleeding diathesis has been mentioned and in this patient the diagnosis was not made for several days. The possibility of disseminated intravascular coagulation should be considered in patients with both acute and chronic liver disease who develop a bleeding diathesis with unusual features. Therapy with heparin in an established case, is logical, and, as in this patient, may be life saving. It should be undertaken, however, with circumspection.
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